Brazil’s National Health Surveillance Agency, Anvisa, has published lists of recognized technical standards for medical devices, with the objective of improving regulatory transparency, predictability and harmonisation.
The initiative was published on 22 October 2026 and is intended to support manufacturers and importers in identifying appropriate technical references for the development and regularisation of medical devices in Brazil. 1792963587396
Supporting Regulatory Transparency
Anvisa states that making the lists publicly available strengthens regulatory transparency and predictability and contributes to greater harmonisation of the criteria used in medical device regularisation. 1792963587396
The initiative is being led by the Agency’s General Management of Health Products Technology (GGTPS).
Its objective is to help companies plan product development and identify the most appropriate technical references for:
demonstrating compliance;
preparing technical dossiers;
supporting medical device regularisation. 1792963587396
Recognized Standards Can Support Compliance
According to Anvisa, recognized technical standards may be used to support demonstration of compliance with applicable safety and performance requirements under Brazilian health regulations.
The Agency also notes that the initiative brings Brazilian evaluation criteria closer to internationally recognised technical references. 1792963587396
For manufacturers, this can provide greater clarity when selecting standards to support regulatory evidence.
Scope of the Standards
The recognized standards cover several stages of the medical device lifecycle, including:
development;
manufacturing;
evaluation;
verification;
validation. 1792963587396
This means the lists may be relevant across design and development, technical documentation and conformity demonstration activities.
Three Initial Lists
Anvisa currently identifies three groups of recognized standards:
List of Cross-Cutting Recognized Technical Standards for Medical Devices — Version 1.0
List of Recognized Technical Standards for Implantable Materials in Orthopedics — Version 1.1
List of Recognized Technical Standards for Healthcare Materials — Version 0.0 1792963587396
These lists provide manufacturers with a structured starting point for identifying applicable technical references.
Cross-Cutting Medical Device Standards
The cross-cutting list is particularly relevant because it may include standards that apply across multiple medical device categories.
For manufacturers, such standards can support common areas including:
safety and performance;
verification and validation;
quality and technical documentation;
product development;
testing strategies.
The publication of a consolidated list may therefore help companies establish more consistent regulatory strategies.
Orthopedic Implant Materials
Anvisa has also published a dedicated list covering implantable materials in orthopedics.
This area is particularly relevant for higher-risk devices where material performance, mechanical characteristics, biocompatibility and long-term clinical use may require extensive technical evidence.
The dedicated list may help manufacturers identify technical references relevant to the development and evaluation of orthopedic implant materials.
Healthcare Materials
A third list covers materials for use in healthcare.
This reflects Anvisa’s broader approach of organising recognized standards by product area while also maintaining cross-cutting technical references.
The current version of this list is identified as Version 0.0, indicating an early stage in the development of this particular standards collection. 1792963587396
A Dynamic Standards Framework
Anvisa makes clear that the project is intended to be dynamic.
The lists will be reviewed continuously, while maintaining a history of updates. 1792963587396
The Agency also anticipates expanding the scope to include additional product categories in response to:
technological evolution;
regulatory needs;
international best practices. 1792963587396
This means manufacturers should monitor future versions of the lists rather than treating the current publication as static.
Greater Alignment With International References
One of the main objectives of the initiative is to bring Brazilian evaluation practices closer to internationally recognised technical standards.
For multinational manufacturers, this may support greater alignment between evidence generated for Brazil and evidence used in other jurisdictions.
Potential benefits include:
more consistent technical documentation;
improved regulatory planning;
reduced uncertainty when selecting standards;
greater reuse of internationally generated evidence.
Impact on Medical Device Manufacturers
For manufacturers planning or maintaining medical device registrations in Brazil, the new lists provide an important reference for regulatory strategy.
Companies should consider reviewing:
currently applied standards;
design and development documentation;
verification and validation plans;
technical dossiers;
product-specific test strategies;
gaps between internal standards and newly recognised references.
The publication may be especially useful during early product development, where the selection of appropriate technical standards can influence testing, documentation and regulatory timelines.
Impact on Importers
Anvisa also identifies importers as a key audience for the initiative. 1792963587396
Importers supporting foreign manufacturers in the Brazilian market should therefore ensure that regulatory documentation and technical evidence are aligned with the standards recognised by the Agency.
This may also improve communication between manufacturers, local importers and regulatory teams when preparing submissions.
What Companies Should Monitor
Because the project will be continuously updated, manufacturers and importers should establish a process for monitoring:
new versions of the lists;
newly added technical standards;
revised standards;
new product categories;
changes in Anvisa expectations.
Early identification of changes can help companies assess whether additional testing or documentation updates may be needed.
Impact on Regulatory Strategy
The publication of recognized standards represents an important step toward greater regulatory predictability in Brazil.
For regulatory teams, the lists may provide clearer evidence of which technical references Anvisa considers suitable to support demonstration of compliance.
This can improve planning throughout the device lifecycle and reduce uncertainty during dossier preparation.
